Non-alcoholic fatty liver disease (NAFLD) represents a significant and growing public health concern in the global medical community. Characterized by the accumulation of excess fat in the liver of individuals who consume little to no alcohol, NAFLD encompasses a disease spectrum from simple steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, and cirrhosis.
Afflicting approximately 25% of the global population, NAFLD prevalence is escalating in tandem with the rising incidence of obesity and type 2 diabetes. The prevalence is highest in the Middle East and South America and lowest in Africa. However, the disease is not confined to these regions and is an escalating concern worldwide.
The pathogenesis of NAFLD is multifaceted, involving genetic predisposition, insulin resistance, and metabolic syndrome. The 'two-hit' hypothesis has been widely accepted to explain the progression from simple steatosis to NASH. The first 'hit' involves the accumulation of triglycerides in the liver, while the second 'hit' leads to inflammation, cell death, and fibrosis.
Proactive management of NAFLD is critical for preventing disease progression and complications. Lifestyle modifications including diet changes and physical activity remain first-line interventions. Pharmacotherapy may be considered in patients with NASH and significant fibrosis, particularly those at high risk of progression. Emerging therapies targeting various aspects of NAFLD pathophysiology are under investigation.
NAFLD is a significant global health burden with a complex pathophysiology. Proactive identification and management are crucial to mitigate disease progression and associated complications. As healthcare professionals, maintaining an up-to-date understanding of this disease and its management strategies is critical to improving patient outcomes.
1.
Early cancer detection during pregnancy and the postpartum period may be aided by breast milk examination.
2.
Global warming could be driving up women's cancer risk, find researchers
3.
Use of social media during pregnancy may increase depression.
4.
Pickleball program boosts health and wellness for cancer survivors, study finds
5.
Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.
1.
The Mysterious Pain of Scrotal Hematoma: A Guide to Diagnosis and Treatment
2.
Base Editing for Rare Blood Diseases: Mechanisms, Clinical Applications, and Future Directions
3.
Immune Escape Landscapes in Solid Tumors
4.
Case Study: The Role of Machine Learning in the Detection of Skin Cancer
5.
How EPCORITAMAB is Revolutionizing the Treatment of Cancer
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
2.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
3.
How Nutrition Can Support Patients During Cancer Care
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation